Form 4: Rallybio Corp Director, Christine A. Nash, Acquires Options

Christine A. Nash, a director of Rallybio Corp, reports the acquisition of options to purchase 28,500 shares of common stock.

Summary

• On May 13, 2025, Christine A. Nash, a director of Rallybio Corp, acquired options to purchase 28,500 shares of the company's common stock.
• The options were granted under the company's 2021 Equity Incentive Plan.
• The options vest on the earlier of May 13, 2026, or the date of the company's 2026 Annual Meeting of Stockholders.
• The expiration date for the options is May 13, 2035.
• The exercise price of the options is $0.30.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a routine stock option grant. It doesn't inherently convey positive or negative sentiment.

Positives

• The granting of options to a director aligns their interests with those of the shareholders, potentially incentivizing them to work towards the company's success.

Industry Context

This filing is a routine disclosure of stock option grants to a company director, a common practice in publicly traded companies to incentivize executives and align their interests with shareholders.

Stakeholder Impact

• The option grant could potentially benefit shareholders if it incentivizes the director to improve company performance.

Key Dates

Keywords

options, director, Rallybio Corp, RLYB, equity incentive plan, beneficial ownership, Form 4